| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |